Insider Stock Trading History of Clark William D


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Clark William D since year 2005. The trader's CIK number is 1355415. At the time of this reporting, Clark William D is the President and CEO of Genocea Biosciences, Inc. . (stock ticker symbol GNCA). See this page for all insider trading activities at Genocea Biosciences, Inc. .

Note that in the past Clark William D also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Clark William D since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-01-17 GNCA Genocea Biosciences, Inc. Buy 25,000 .80 20,000
2016-11-07 GNCA Genocea Biosciences, Inc. Buy 2,800 3.49 9,772
2015-12-16 GNCA Genocea Biosciences, Inc. Buy 3,800 6.45 24,510
2014-12-12 GNCA Genocea Biosciences, Inc. Option Ex 19,807 2.86 56,648
2014-09-02 GNCA Genocea Biosciences, Inc. Option Ex 20,000 2.86 57,200
2010-02-19 VNDA Vanda Pharmaceuticals Inc. Sale 9,522 10.65 101,409
2010-02-18 VNDA Vanda Pharmaceuticals Inc. Option Ex 25,000 .00 0
2009-12-14 VNDA Vanda Pharmaceuticals Inc. Sale 217,749 11.05 2,406,344
2009-12-14 VNDA Vanda Pharmaceuticals Inc. Option Ex 295,550 .33 97,827
2009-05-11 VNDA Vanda Pharmaceuticals Inc. Option Ex 25,000 .00 0
2008-08-07 VNDA Vanda Pharmaceuticals Inc. Buy 50,000 .99 49,500
2007-10-01 VNDA Vanda Pharmaceuticals Inc. Option Ex 3,200 .33 1,059
2007-10-01 VNDA Vanda Pharmaceuticals Inc. Sale 3,200 13.87 44,384
2007-08-01 VNDA Vanda Pharmaceuticals Inc. Sale 3,200 18.84 60,288
2007-08-01 VNDA Vanda Pharmaceuticals Inc. Option Ex 3,200 .33 1,059
2007-06-01 VNDA Vanda Pharmaceuticals Inc. Option Ex 3,200 .33 1,059
2007-06-01 VNDA Vanda Pharmaceuticals Inc. Sale 3,200 20.13 64,406
2007-04-02 VNDA Vanda Pharmaceuticals Inc. Sale 3,200 24.13 77,216
2007-04-02 VNDA Vanda Pharmaceuticals Inc. Option Ex 3,200 .33 1,059
2007-02-01 VNDA Vanda Pharmaceuticals Inc. Option Ex 3,200 .33 1,056
2007-02-01 VNDA Vanda Pharmaceuticals Inc. Sale 3,200 29.56 94,585
2006-12-11 VNDA Vanda Pharmaceuticals Inc. Sale 15,000 26.28 394,155
2006-12-11 VNDA Vanda Pharmaceuticals Inc. Option Ex 15,000 .33 4,950
2006-11-07 VNDA Vanda Pharmaceuticals Inc. Option Ex 400 .33 132
2006-11-08 VNDA Vanda Pharmaceuticals Inc. Option Ex 18,600 .33 6,138
2006-11-07 VNDA Vanda Pharmaceuticals Inc. Sale 400 11.55 4,622
2006-11-08 VNDA Vanda Pharmaceuticals Inc. Sale 12,300 11.19 137,600
2006-11-08 VNDA Vanda Pharmaceuticals Inc. Sale 6,300 11.57 72,891

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Clark William D (President and CEO of Genocea Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.